Skip directly to content

11. Globalni skup o hemofiliji – 1.dio: Genska terapija

11. Globalni skup o hemofiliji – Sastanak održan u organizaciji neovisnog Upravljačkog povjerenstva  i pod pokroviteljstvom tvrtke Pfizer u razdoblju od 24. do 26. Studenog 2020. godine. Članovi upravljačkog povjerenstva: Gerry Dolan (UK), Jan Astermark (Švedska), Cedrid Hermans (Belgija) i Cristina Catarino (Portugal).

 

Haemophilia gene therapy: a voyage of discovery – where are we now, and where next?
Barbara Konkle (USA)
 

 

AAV seropositivity and eligibility: what does it really mean?
Maria Limberis (USA)


 

Haemophilia gene therapy and inhibitors: the final frontier?
Jan Astermark (Sweden)


 

Planning for life with gene therapy: considerations for reproduction
Barbara Konkle (USA)


 

Gene therapy in children: if not now, when?
Steve Pipe (USA)


 

Gene therapy as a genetically modified material: are we ready for this in our clinic?
Gerry Dolan (UK)


 

 

 

PP-HEM-EEP-0016, Datum izrade: travanj, 2021.